Make your money go further for just 25p per day

News & Insights

AIM heroes, villains and an exciting IPO, at last

Accounting issues are keeping AIM investors on their toes, but at least there is finally a new company to inject some enthusiasm

Access the full Investor’s Champion Portfolio

Register to view the full portfolio which can be bought via our associates at Fundamental Asset.

Get FREE access now

Already a member? Login

For access to the top news and insights from the investment world

REGISTER FREE TODAY

Our MORNING EMAIL delivers the daily news you need to make your money go further straight into your inbox.

SIGN UP
Investors Clinic
PREMIUM

Dividend dogs vs diamonds: Part 1 – beware the yield

21/05/2019
Investors Clinic
PREMIUM

Dividend dogs vs diamonds: Part 2 – paying the price of quality

23/05/2019
Podcasts

More than Money: Shield Therapeutics

22/05/2019

Search for AIM companies qualifying for relief from Inheritance Tax!

Use our unique screening tool to identify Inheritance Tax planning AIM companies

This search will take you to the separate AIMsearch web site which requires a different user name and password to this Investor's Champion site.

News & Insight


M&S and Royal Mail: Is it too late to turn things around?

22/05/2019

Vodafone cuts dividend: are the shares still worth holding?

14/05/2019

Scapa Group - Bonkers valuation of the week

21/05/2019

Ride hailing – the S-Uber-b way

03/04/2019

Money Management


Reviewing the robo-advisers

21/03/2019

Busting the myths of the independent financial adviser industry

09/05/2019

Robo-wars: Investec axes Click & Invest

16/05/2019

Help to Buy: has it worked?

26/02/2019

Companies Analysed


PREMIUM

Portfolio Flash News: May

20/05/2019
PREMIUM

ESG investment: Are plants the future of food?

17/05/2019
PREMIUM

Can fast growing Keystone Law maintain its pace?

10/05/2019

Should investors be worried about social consciousness?

28/03/2019

LATEST FROM INVESTOR'S CHAMPION

AIM heroes, villains and an exciting IPO, at last

Accounting issues are keeping AIM investors on their toes, but at least there is finally a new company to inject some enthusiasm

Dividend dogs vs diamonds: Part 2 – paying the price of quality

Quality shares with reliable dividends have become very expensive as investors struggle to find anywhere better to put their money.

M&S and Royal Mail: Is it too late to turn things around?

22/05/2019 · Marks & Spencer · Ocado · Royal Mail
Marks & Spencer and Royal Mail - two former British icons - are both facing an uphill battle as they attempt to win back customers in the age of Amazon.

More than Money: Shield Therapeutics

22/05/2019 · Shield Therapeutics PLC
We talk nasty shocks, drugs approvals and the value of patience with Shield Therapeutics' founder and chief executive Carl Sterritt

Scapa Group - Bonkers valuation of the week

21/05/2019 · Scapa Group
Scapa Group trades at a premium valuation yet generates relatively modest real cash returns

Dividend dogs vs diamonds: Part 1 – beware the yield

Vodafone’s cut is proof that it is right to fear shares which yield over 8%